• "I didn't know it was going to be like this.": unprepared for end-of-Life care, the experiences of care aides care in long-term care
• A 2-Year, Randomized, Clinical Trial Examining the Effects of Speed of Processing Cognitive Training on Quality-of-Life Indicators in Adults With HIV-Associated Neurocognitive Disorder in Birmingham, Alabama: Results of the Think Fast Study
• A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation
• AIDS Dementia Complex: Neurotoxicity in AIDS Patients
• Alterations in glutamate, arginine, and energy metabolism characterize cerebrospinal fluid and plasma metabolome of persons with HIV-associated dementia
• Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?
• Awareness and Knowledge of HIV-Associated Neurocognitive Disorder Among Middle-Aged and Older People Living With HIV/AIDS in Southern Nevada: Implications for HIV/AIDS Community-Based Education Programs
• Beyond Frequency Bands: Complementary-Ensemble-Empirical-Mode-Decomposition-Enhanced Microstate Sequence Non-Randomness Analysis for Aiding Diagnosis and Cognitive Prediction of Dementia
• CCL2 is required for initiation but not persistence of HIV infection mediated neurocognitive disease in mice
• Central Nervous System Complications of HIV in Children
• Central Nervous System Effects of Early HIV Infection and Consequences of Antiretroviral Therapy Initiation during Acute HIV
• Cerebral abnormalities in HIV-infected individuals with neurocognitive impairment revealed by fMRI
• Circulating plasma-derived extracellular vesicles expressing bone and kidney markers are associated with neurocognitive impairment in people living with HIV
• Cognitive impairment in people with HIV: one step closer to criteria that capture neurocognitive diversity
• Comprehensive analyses identify potential biomarkers for encephalitis in HIV infection
• Computer use: a protective factor for cognition in aging and HIV disease?
• Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia
• Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study
• Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders
• Dramatic Improvement of MRI Abnormalities of HIV Encephalopathy after Suppressive Antiretroviral Therapy
• Dysregulation of Gut Microbiota-Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus-Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic Analysis
• Evaluation of peripheral and central olfactory pathways in HIV-infected patients by MRI
• Frailty and HIV-associated neurocognitive disorder are only modestly associated
• Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review
• Hand surgery in a new "hand-brain" era: change the hand, rebuild the brain
• Health disparities in mortality among individuals with HIV-associated dementia in South Carolina
• Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective
• HIV associated neurocognitive disorder screening and diagnosis pathways in Australia: a scoping review and international implications
• HIV encephalopathy is contributed by macrophages and microglia
• HIV-1 gp120 Protein Activates Cyclin-Dependent Kinase 1, a Possible Link to Central Nervous System Cell Death
• HIV-Associated Dementia: Associated Factors and Characteristics of Cognitive Domain Abnormalities in Elderly People Living with HIV Treated with Highly Active Antiretroviral Therapy
• HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology
• Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV
• Human immunodeficiency virus-associated dementia complex with positive 14-3-3 protein in cerebrospinal fluid: A case report
• Imaging of Brain Structural and Functional Effects in People With Human Immunodeficiency Virus
• Lack of Association of Vascular Risk Factors with HIV-Associated Neurocognitive Disorders in cART-Treated Adults Aged ≥ 50 Years in Tanzania
• Neurocognitive Disorders in HIV-positive Patients
• Neuropathogenic role of astrocyte-derived extracellular vesicles in HIV-associated neurocognitive disorders
• Pathology and pathogenesis of HIV encephalopathy
• Prevalence and associated factors of neurocognitive disorder among people living with HIV/AIDS in the South Gondar zone primary hospitals, North-West Ethiopia: an institution-based cross-sectional study
• Screening HIV associated neurocognitive disorders using international HIV dementia scale: closing the gap through an educational intervention for healthcare workers
• SI for NeuroAIDS: CNS function and dysfunction when HIV is a chronic disease
• Simian immunodeficiency virus-infected rhesus macaques with AIDS co-develop cardiovascular pathology and encephalitis
• The clinical utility of three frailty measures in identifying HIV-associated neurocognitive disorders
• The cognitive remediation of attention in HIV-associated neurocognitive disorders (HAND): A meta-analysis and systematic review
• The magnitude of neurocognitive disorders and associated factors among people living with HIV AIDS facilities in Bahir Dar City Ethiopia
• The path to healthy ageing in China: a Peking University-Lancet Commission
• Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system